| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/22/1999 | WO1999036095A1 PHARMACEUTICAL COMPOSITIONS COMPRISING A COMPOUND HAVING DOPAMINE (D2) RECEPTOR AGONIST ACTIVITY AND A COMPOUND (B) HAVING β2-ADRENORECEPTOR AGONIST ACTIVITY |
| 07/22/1999 | WO1999036090A1 Oral delivery of nucleic acid vaccines by particulate complexes |
| 07/22/1999 | WO1999036089A1 Genetic immunization with co-delivery of nucleic acid and cytokines in a single vehicle |
| 07/22/1999 | WO1999036080A1 St. john's wort and methyl donor composition and uses thereof |
| 07/22/1999 | WO1999036076A1 Composition containing propargylamine for enhancing cancer therapy |
| 07/22/1999 | WO1999036075A1 Oral oil sorbing composition |
| 07/22/1999 | WO1999036074A1 Use of 8-cl-camp in prevention of restenosis of arterial walls |
| 07/22/1999 | WO1999036073A1 Method of inhibiting interleukin-12 signaling |
| 07/22/1999 | WO1999036072A1 Pyrimidin 3-oxide compounds suitable for the treatment of pathologies of the skeletal muscle, in particular for the treatment of the hypokalemic paralysis |
| 07/22/1999 | WO1999036071A1 Biodegradable polymer matrices for sustained delivery of anesthetics |
| 07/22/1999 | WO1999036070A1 Il-8 receptor antagonists |
| 07/22/1999 | WO1999036069A1 Il-8 receptor antagonists |
| 07/22/1999 | WO1999036068A1 Potassium channel activators |
| 07/22/1999 | WO1999036067A1 Modulation of hair growth |
| 07/22/1999 | WO1999036066A1 Pharmaceutical composition comprising at least one aminopeptidase a inhibitor |
| 07/22/1999 | WO1999036065A1 Medicinal compositions |
| 07/22/1999 | WO1999036064A2 Methods of treating tardive dyskinesia and other movement disorders |
| 07/22/1999 | WO1999036063A2 Vanadium (iv) metallocene complexes having spermicidal activity |
| 07/22/1999 | WO1999036062A1 Topical administration of angiotensin-converting enzyme inhibitors |
| 07/22/1999 | WO1999036060A1 Oral liquid compositions |
| 07/22/1999 | WO1999036055A1 Autoclavable pharmaceutical compositions containing a chelating agent |
| 07/22/1999 | WO1999036050A1 Compositions and method for protecting skin from uv induced immunosuppression and skin damage |
| 07/22/1999 | WO1999036030A2 Pharmaceutical composition and method for treating di-hydroxytestosterone dependent conditions |
| 07/22/1999 | WO1999035912A1 Tuberculocidal disinfectant |
| 07/22/1999 | WO1999030157A3 Neuropilins in methods for diagnosis and prognosis of cancer |
| 07/22/1999 | WO1999029319A3 Chemical compounds for use as anxiolytic agents and a method for the identification of anxiolytic compounds |
| 07/22/1999 | WO1999029309A3 2,2'-bi-1h-pyrrole derivatives useful in the treatment of leukemia brought on by htlv-i |
| 07/22/1999 | WO1999027921A3 Compositions and methods for modulating the activity of fibroblast growth factor |
| 07/22/1999 | WO1999026632B1 Phospholipids having antimicrobial activity with or without the presence of antimicrobials |
| 07/22/1999 | WO1999025690A3 Advanced glycation end-product intermediaries and post-amadori inhibition |
| 07/22/1999 | WO1999024042A3 Stable antiandrogenic gel composition |
| 07/22/1999 | WO1999024022A3 Isoquinoline derivatives for treating disorders associated with 5ht7 receptors |
| 07/22/1999 | WO1999023208A3 RIBOZYMES TARGETED TO IL-15 mRNA |
| 07/22/1999 | WO1999022724A3 Extended release formulation containing venlafaxin |
| 07/22/1999 | WO1999021830A8 Process for stereoselective synthesis of prostacyclin derivatives |
| 07/22/1999 | WO1999021555A3 Adenosine a3 receptor antagonists |
| 07/22/1999 | WO1999017712A3 Tightening and/or reducing the size of body parts containing fat cells |
| 07/22/1999 | WO1998059040A3 Human catalytic telomerase sub-unit and its diagnostic and therapeutic use |
| 07/22/1999 | WO1998055495B1 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof |
| 07/22/1999 | DE19801821A1 Use of N-substituted glycine derivatives in tuberculocidal disinfectant |
| 07/22/1999 | DE19801811A1 Oral pharmaceutical composition containing antisecretory compound useful for inhibiting stomach acid secretion in treatment of esophagitis, gastritis, duodenitis, gastric ulcers and duodenal ulcers |
| 07/22/1999 | DE19801647A1 New beta, gamma-fused lactone glutamate receptor modulators for treating cerebral ischemia, cranial or brain trauma, pain or CNS-mediated spasms |
| 07/22/1999 | DE19801646A1 New bicyclic lactone glutamate receptor modulators for treating cerebral ischemia, cranial/brain trauma, pain or CNS-mediated spasms |
| 07/22/1999 | DE19801636A1 New bi:cyclic lactone glutamate receptor modulators |
| 07/22/1999 | CA2319063A1 Il-8 receptor antagonists |
| 07/22/1999 | CA2318693A1 Composition containing propargylamine for enhancing cancer therapy |
| 07/22/1999 | CA2318664A1 Nucleotide expression systems with reduced immunogenicity for use in gene therapy |
| 07/22/1999 | CA2318663A1 Methods and compositions for gene delivery |
| 07/22/1999 | CA2318555A1 Thiophene nitrone compounds |
| 07/22/1999 | CA2318498A1 Genetic immunization with co-delivery of nucleic acid and cytokines in a single vehicle |
| 07/22/1999 | CA2318493A1 Oral delivery of nucleic acid vaccines by particulate complexes |
| 07/22/1999 | CA2318402A1 Regulation of biological events using multimeric chimeric proteins |
| 07/22/1999 | CA2318393A1 A substance having an apoptosis-inducing ability |
| 07/22/1999 | CA2318362A1 Triazine antiviral compounds |
| 07/22/1999 | CA2318357A1 Thioether furan nitrone compounds |
| 07/22/1999 | CA2318236A1 Oral oil sorbing composition |
| 07/22/1999 | CA2318199A1 Platelet adp receptor inhibitors |
| 07/22/1999 | CA2318195A1 Il-8 receptor antagonists |
| 07/22/1999 | CA2318159A1 Vanadium (iv) metallocene complexes having spermicidal activity |
| 07/22/1999 | CA2317942A1 Alkenyldiarylmethane non-nucleoside hiv-1 reverse transcriptase inhibitors |
| 07/22/1999 | CA2317895A1 Ribozymal nucleic acids cleaving ccr5 or cxcr4 |
| 07/22/1999 | CA2317815A1 Neisseria meningitidis antigens |
| 07/22/1999 | CA2317760A1 Piperazino derivatives as neurokinin antagonists |
| 07/22/1999 | CA2317728A1 Novel crystalline complexes of baccatin iii with imidazole, 2-methylimidazole or isopropanol |
| 07/22/1999 | CA2317671A1 St. john's wort and methyl donor composition and uses thereof |
| 07/22/1999 | CA2317536A1 Aminosulphonylbenzamide derivatives as modulators of the activity of neuronal calcium channels |
| 07/22/1999 | CA2317439A1 Methods of synthesizing and screening inhibitors of bacterial nad synthetase enzyme, compounds thereof, and methods of treating bacterial and microbial infections with inhibitors of bacterial nad synthetase enzyme |
| 07/22/1999 | CA2316853A1 Potassium channel activators |
| 07/22/1999 | CA2315760A1 Tuberculocidal disinfectant |
| 07/22/1999 | CA2315299A1 Fatty acid synthase mrna binding protein |
| 07/22/1999 | CA2315219A1 Triazolo-pyridazine derivatives as ligands for gaba receptors |
| 07/22/1999 | CA2314148A1 Pharmaceutical formulations and processes for their preparation |
| 07/22/1999 | CA2309546A1 N-[2-(5-benzyloxycarbonyl-amino-6-oxo-2-(4-fluorophenyl)-1,6-dihydro-1-pyrimidinyl)acetoxyl]-l-aspartic acid aldehyde as an in vivo inhibitor of interleukin-1.beta. converting enzyme (ice) |
| 07/22/1999 | CA2259773A1 Antifibrotic agent |
| 07/21/1999 | EP0930313A1 1-isothiazolidinone derivatives of azetidine-2-one, process for the preperation thereof and the use thereof |
| 07/21/1999 | EP0930310A1 Isocoumarin derivatives and use thereof in drugs |
| 07/21/1999 | EP0930302A2 Benzosulfone derivatives |
| 07/21/1999 | EP0930299A1 Propionic acid derivatives and applications thereof |
| 07/21/1999 | EP0930297A1 A process for preparing naphthyridones and intermediates |
| 07/21/1999 | EP0930077A1 Cyclodextrin compositions comprising an avermectin or a milbemycin derivative |
| 07/21/1999 | EP0930076A1 Medicinal compositions |
| 07/21/1999 | EP0930075A1 Methods for preventing, inhibiting or treating graft rejection reactions in graft-versus-host disease (gvhd) and organ transplantation |
| 07/21/1999 | EP0930073A1 Process for preparation of spermicidal agent |
| 07/21/1999 | EP0930071A1 Use of flavine-adenine-dinucleotide for the preparation of ophthalmic compositions for the treatment of the dry eye |
| 07/21/1999 | EP0930070A1 Stable aspirin ointment preparations |
| 07/21/1999 | EP0930069A2 Compositions for the reduction of scarring |
| 07/21/1999 | EP0930068A2 Trovafloxacin mesylate tablet |
| 07/21/1999 | EP0930067A2 Mmp inhibitors for the treatment of ocular angiogenesis |
| 07/21/1999 | EP0930066A2 Low tack lotion, gels and creams |
| 07/21/1999 | EP0930065A2 Alcohol based anti-microbial compositions with cosmetic appearance |
| 07/21/1999 | EP0929679A2 Histidine-tagged shiga toxins, toxoids, and protein fusions with such toxins and toxoids, methods for the purification and preparation thereof |
| 07/21/1999 | EP0929673A2 Tumor proteins |
| 07/21/1999 | EP0929671A1 Method for treating amyotrophic lateral sclerosis |
| 07/21/1999 | EP0929578A1 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 07/21/1999 | EP0929571A1 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators |
| 07/21/1999 | EP0929569A1 Methods of alleviating neuropathic pain using prosaposin-derived peptides |
| 07/21/1999 | EP0929565A2 Nitrate esters of corticoid compounds and pharmaceutical applications thereof |
| 07/21/1999 | EP0929563A1 6-o-substituted ketolides having antibacterial activity |
| 07/21/1999 | EP0929562A1 Acid-functionalized saccharides as polyvalent anti-infectives |
| 07/21/1999 | EP0929557A2 (o-ACYL-p-N-ACYLAMINO-PHENYL)-O-PHOSPHOETHANOLAMINES |